Show Notes
Drones are already being used to transport medicines in several countries around the world, including the United States, Australia, Switzerland and Rwanda, but what’s the story in the UK, where the road infrastructure is good and the airspace is small and busy? Is there a need for medical drone deliveries? Are they safe and would they be a viable option for the NHS?
These are questions that senior features editor Dawn Connelly investigates in this episode of The PJ Pod. We hear from the experts behind several projects across the UK as they test the feasibility of using drones to deliver NHS medicines.
Thank you to Paul Royall, senior lecturer in pharmaceutics at King’s College London; Arthur Mendez, a research and development engineer with drone development company HeroTech8; Mark Knowles, head of production at Northumbria Healthcare NHS Foundation Trust; Christopher Law, co-founder of healthcare drone logistics start-up Apian; Jamie Hogg, clinical lead for the CAELUS project for the north of Scotland; and Anthony McDavitt, director of pharmacy for NHS Shetland.
This episode was produced by Geoff Marsh, with editorial support from executive editor Carolyn Wickware.
More from The PJ Pod
For Tase Oputu, becoming the first president of the Royal College of Pharmacy is “the greatest honour of my career”, and she says the move to a royal college is already changing how pharmacy is received by policymakers.
In this episode of Pharmacy Inside Jobs, senior editor, research and learning Alex Clabburn talks to Ed Hindle.
Electronic Prescription System (EPS) nominations connect patients with the pharmacy where they can collect their medication – and often access other services, help and advice while they’re there.
In this episode of Pharmacy Inside Jobs, Joanna Robertson, senior clinical reporter, talks to Mark Stuart, a sports pharmacist whose 25-year career has spanned Olympic, Paralympic and Commonwealth games, as well as anti-doping education at the International Testing Agency.
In this episode of The PJ Pod, senior features editor Siobhan Chan examines how the issue of antimicrobial resistance (AMR) is being communicated outside of traditional clinical and policy settings.